VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LRMR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LRMRLarimar Therapeutics, Inc.
$3.20$274M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLRMRQuarterly Financials

Larimar Therapeutics, Inc. (LRMR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Larimar Therapeutics, Inc. (LRMR) quarterly income statement — complete revenue, gross profit & net income history

LRMR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold0000000080K81K0000000000
COGS % of Revenue--------------------
Gross Profit00000000-80K-81K0000000000
Gross Margin %--------------------
Gross Profit Growth %----100%100%--------------
Operating Expenses31.12M64.02M49.5M27.79M31.19M31.29M18.26M24.6M16.65M14.08M10.34M9.62M7.64M10.44M8.51M8.69M8.89M9.09M16.73M12.54M
OpEx % of Revenue--------------------
Selling, General & Admin6.09M4.64M4.67M4.42M4.64M4.55M4.34M4.92M3.79M3.51M3.75M3.75M3.08M3.22M2.93M3.04M3.08M2.79M2.7M3.44M
SG&A % of Revenue--------------------
Research & Development25.03M59.37M44.93M23.37M26.55M26.74M13.92M19.68M12.86M10.57M6.58M5.88M4.56M7.22M5.58M5.64M5.81M6.29M14.03M9.1M
R&D % of Revenue--------------------
Other Operating Expenses00-100K00000000000000000
Operating Income-31.12M-64.02M-49.5M-27.79M-31.19M-31.29M-18.26M-24.6M-16.73M-14.16M-10.34M-9.62M-7.64M-10.44M-8.51M-8.69M-8.89M-9.09M-16.73M-12.54M
Operating Margin %--------------------
Operating Income Growth %0.23%-104.58%-171.02%-12.98%-86.38%-120.96%-76.65%-155.71%-119.12%-35.66%-21.45%-10.74%14.07%-14.89%49.12%30.74%26.59%36.89%-61.88%-10.04%
EBITDA-31.12M-63.93M-49.41M-27.7M-31.1M-31.22M-18.19M-24.51M-16.65M-14.08M-10.26M-9.54M-7.56M-10.36M-8.44M-8.61M-8.8M-9M-16.64M-12.47M
EBITDA Margin %--------------------
EBITDA Growth %-0.05%-104.8%-171.64%-13.03%-86.74%-121.69%-77.24%-156.83%-120.32%-35.9%-21.66%-10.9%14.15%-15.15%49.31%30.96%26.83%37.28%-61.81%-9.67%
D&A (Non-Cash Add-back)087K88K87K88K77K74K87K80K81K76K76K78K78K77K81K82K88K88K77K
EBIT-31.12M-64.02M-47.71M-27.79M-31.19M-31.29M-18.26M-24.6M-16.73M-14.16M-10.34M-9.62M-7.64M-10.44M-8.51M-8.69M-8.89M-9.09M-16.73M-12.54M
Net Interest Income00000000000000000000
Interest Income00000000000000000000
Interest Expense00000000000000000000
Other Income/Expense1.5M1.52M1.79M1.61M1.91M2.47M2.77M2.97M2.08M1.17M1.27M1.25M1.11M1.01M193K20K-56K-48K-75K-66K
Pretax Income-29.61M-62.5M-47.71M-26.18M-29.28M-28.82M-15.5M-21.63M-14.65M-12.99M-9.06M-8.37M-6.53M-9.43M-8.32M-8.67M-8.94M-9.13M-16.8M-12.61M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-29.61M-62.5M-47.71M-26.18M-29.28M-28.82M-15.5M-21.63M-14.65M-12.99M-9.06M-8.37M-6.53M-9.43M-8.32M-8.67M-8.94M-9.13M-16.8M-12.61M
Net Margin %--------------------
Net Income Growth %-1.13%-116.83%-207.84%-21.06%-99.82%-121.84%-71%-158.51%-124.55%-37.86%-8.94%3.47%27.03%-3.19%50.49%31.26%26.02%35.69%-63.57%-11.29%
Net Income (Continuing)-29.61M-62.5M-47.71M-26.18M-29.28M-28.82M-15.5M-21.63M-14.65M-12.99M-9.06M-8.37M-6.53M-9.43M-8.32M-8.67M-8.94M-9.13M-16.8M-12.61M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.35-0.73-0.61-0.41-0.46-0.45-0.24-0.34-0.27-0.30-0.21-0.19-0.12-0.35-0.37-0.47-0.49-0.50-0.92-0.79
EPS Growth %23.91%-62.22%-154.17%-20.59%-70.37%-50%-14.29%-78.95%-125%14.29%43.24%59.57%75.51%30%59.78%40.51%35.53%43.82%-43.75%34.71%
EPS (Basic)-0.35-0.73-0.61-0.41-0.46-0.45-0.24-0.34-0.27-0.30-0.21-0.19-0.12-0.35-0.37-0.47-0.49-0.50-0.92-0.79
Diluted Shares Outstanding85.18M85.18M78.32M64.03M63.96M63.81M63.81M63.8M53.55M43.91M43.9M43.9M43.9M23.99M22.23M18.34M18.34M18.34M18.29M16M
Basic Shares Outstanding85.18M85.18M78.32M64.03M63.96M63.81M63.81M63.8M53.55M43.91M43.9M43.9M43.9M23.99M22.23M18.34M18.34M18.34M18.29M16M
Dividend Payout Ratio--------------------